Safety and Potential Effect of a Single Intracavernous Injection of Autologous Adipose-Derived Regenerative Cells in Patients with Erectile Dysfunction Following Radical Prostatectomy: An Open-Label Phase I Clinical Trial

Posted in Clinical Trials & Pilot Studies, Male Sexual Wellness | 1 minute read

March 2016

Martha Kirstine Haahr et al. published “Intracavernous Injection of Autologous Adipose-Derived Regenerative Cells in Patients with Erectile Dysfunction Following Radical Prostatectomy: An Open-Label Phase I Clinical Trial” in EBio Medicine. They completed a human phase 1 trial with autologous adipose-derived regenerative cells (ADRCs) and their results showed that adipose cells are “safe to use and possess potential efficacy in the treatment of ED after RP.”

Click below to read the full study.